Arcutis Bio shelves plans for Phase 2a ARQ-252 trial in vitiligo, shares fall 5%
July 01 2021 - 6:33AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Arcutis Biotherapeutics (NASDAQ:ARQT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Arcutis Biotherapeutics (NASDAQ:ARQT)
Historical Stock Chart
From Apr 2023 to Apr 2024